D. Somjen et al., NONGENOMIC EFFECTS OF AN ANTIIDIOTYPIC ANTIBODY AS AN ESTROGEN MIMETIC IN FEMALE HUMAN AND RAT OSTEOBLASTS, Journal of cellular biochemistry, 65(1), 1997, pp. 53-66
We investigated the early effects of the anti-idiotypic antibody (clon
e 1D(5)), which recognized the estrogen receptor (ER), on cytosolic fr
ee calcium concentration ([Ca2+]i) and its long term effects on creati
ne kinase (CK) specific activity in female human and rat osteoblasts.
These actions were compared to the known membrane and genomic effects
of 17 beta estradiol (E-2). Like E-2, clone 1D(5) increased within 5 s
[Ca2+]i in both cell types by two mechanisms: i) Ca2+ influx through
voltage-gated Ca2+ channels as shown by using EGTA, a chelator of extr
acellular Ca2+, and nifedipine, a Ca2+ channel blocker; 2) Ca2+ mobili
zation from the endoplasmic reticulum as shown by using phospholipase
C inhibitors, such as neomycin and U-73122, which involved a Pertussis
toxin-sensitive G-protein. Clone 1D(5) and E-2 stimulated CK specific
activity in human and rat osteoblasts with ten fold higher concentrat
ions than those needed for the membrane effects (0.1 mu g/ml and 10 pM
, respectively). Both effects were gender-specific since testosterone
and 5 alpha-dihydotesterone were uneffective. Tamoxifen and Raloxifene
, two estrogen nuclear antagonists, inhibited CK response to 1D(5) and
E-2 and Ca2+ response to 1D(5), but not Ca2+ response to E-2. By cont
rast, (Fab')(2) dimer, a proteolytic fragment of 1D(5) with antagonist
properties, inhibited both membrane and genomic effects of 1D(5) and
E-2. In conclusion, these results imply that clone 1D(5) has an estrog
en like activity both at the membrane and nuclear levels in female hum
an and rat osteoblasts. 1D(5) must therefore interact with membrane bi
nding sites, penetrate the cells, and reach the nuclear receptors by a
n as yet uncharacterized mechanism. (C) 1997 Wiley-Liss, Inc.